Loading…

Amelioration of murine dextran sulfate sodium-induced colitis by nuclear factor-κb decoy oligonucleotides

Abstract Background Activation of nuclear factor (NF)-κB has been shown to play a critical role in the pathogenesis of ulcerative colitis (UC). The purpose of the current study was to investigate the effects of NF-κB decoy oligonucleotides (ODNs) on an experimental model of UC. Methods NF-κB decoy O...

Full description

Saved in:
Bibliographic Details
Published in:The American journal of surgery 2009-06, Vol.197 (6), p.797-805
Main Authors: Xiang, Jun Ying, M.D, Wu, Li Guo, M.D, Huang, Xiao Li, M.D, Zhang, Meng, M.D, Pen, Lan, M.D, Ouyan, Qin, M.D, Gan, Hua Tian, M.D., Ph.D
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background Activation of nuclear factor (NF)-κB has been shown to play a critical role in the pathogenesis of ulcerative colitis (UC). The purpose of the current study was to investigate the effects of NF-κB decoy oligonucleotides (ODNs) on an experimental model of UC. Methods NF-κB decoy ODNs were administered in experimental colitis induced by dextran sulfate sodium (DSS). The disease activity index (DAI) and histological score were observed. NF-κB DNA binding activity was assessed by electrophoretic mobility shift assay (EMSA). The expression of tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were measured by reverse transcription polymerase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). Results A significant improvement was observed in DAI and histological score in mice with NF-κB decoy ODNs, and the increase in NF-κB DNA binding activity, myeloperoxidase (MPO) activity, IL-1β, and TNF-a in mice with DSS-induced colitis was significantly reduced following administration of NF-κB decoy ODNs. Conclusions The administration of NF-κB decoy ODNs leads to an amelioration of DSS-induced colitis, suggesting administration of NF-κB decoy ODNs may provide a therapeutic approach for UC.
ISSN:0002-9610
1879-1883
DOI:10.1016/j.amjsurg.2008.04.012